PM Truss urged to put billions into social care

GlaxoSmithKline’s (LON:GSK) CEO Emma Walmsley has said that by 2031, the company plans to make sales of over £33 billion and increase adjusted operating profit by 10 per cent in the next half-decade. However, the company plans to slash ...

The European Union has approved the drug Koselugo, manufactured by AstraZeneca (LON: AZN) and Merck & Co, to treat children above 3 years of age with neurofibromatosis type 1 (NF1), a rare genetic disease. The drug was approved as per the SPRIN...

Summary MHC had generated revenue of £26,146 from the launch of the COVID-19 PCR nasal swab test kit in December 2020. The Company had reported a net loss of negative £3.76 million for FY20. MHC had a cash balance of £465,671...

Summary Tagrisso has been approved by the European Commission (EC) to treat patients with early-stage epidermal growth factor receptor-mutated non-small cell lung cancer. The EC approval came about due to positive results from the ADAURA phase ...

Summary GSK, Sanofi launched the final phase III trials of their delayed Covid vaccine. The phase III trial for the vaccine have 35,000 people enrolled, who are 18 years and above from different countries. The trial would study the efficiency ...

Vectura Group PLC (LON: VEC) is the healthcare stock listed on the London stock exchange. VEC’s shares have generated a return of 77.83% in the last 12 months. VEC is listed on the FTSE 250 index. On 27 May 2021, the Company will hold its An...

Summary Vectura Group shares rallied very sharply on Wednesday, 26 May, hitting a 4-year high The drugmaker has agreed on the terms of acquisition with Carlyle Group Bidco will be acquiring all the share capital of Vectura for a cash considera...

Summary The UK has been ranked as world’s top developed country with the best healthcare system overall. Innova, the world’s largest rapid Covid-19 test maker, recently decided to start manufacturing in the UK. Pfizer, one of the w...

Summary A recent GlobalData survey highlighted a majority of US, and UK healthcare professionals believed the UK is an attractive destination for research and manufacturing in the sector post Brexit. Vaccine maker AstraZeneca’s share drop...

Sumamry As per PHE, the Covid-19 inoculation programme alone has helped in preventing more than 11,000 deaths in England Various medical experts initially believed that there could be severe issues with the people who have received the Covid-19...